News
38m
Vancouver Sun on MSNB.C. restricts sales of two more diabetes drugs amid weight-loss demandThe B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...
The Canadian Press on MSN10m
B.C. limits sales of two more diabetes drugs amid off-label use for weight lossBritish Columbia's Health Ministry is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...
3d
New Scientist on MSNYou don't need to take drugs like Ozempic consistently to lose weightPeople who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
2d
The Brighterside of News on MSNWeight-loss drug Tirzepatide significantly slows breast cancer growth, study findsKey Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.
For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...
This new drug is a jab at Ozempic. Tirzepatide, a weekly injectable that rivals celebrity-favorite Wegovy, is one step closer to approval for weight loss by the Food and Drug Administration after ...
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results